Pier 88 Investment Partners’s Boston Scientific BSX Stock Holding History

Pier 88 Investment Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,200	Closed	-$1.19M	–	98
2024 Q3	$1.19M	Sell	14,200 -26,800	-65%	-$2.11M	0.26%	50
2024 Q2	$3.16M	Buy	41,000 +12,300	+43%	+$900K	0.71%	27
2024 Q1	$1.97M	Buy	+28,700	New	+$1.85M	0.48%	32
2023 Q4	–	Sell	-24,500	Closed	-$1.29M	–	96
2023 Q3	$1.29M	Sell	24,500 -4,191	-15%	-$220K	0.32%	57
2023 Q2	$1.55M	Buy	+28,691	New	+$1.5M	0.38%	44

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pier 88 Investment Partners's BSX Position: Q4 2024 in Review

Pier 88 Investment Partners sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 14,200 shares — an estimated $1.19M sold.

Pier 88 Investment Partners first reported a position in BSX in Q2 2023 and held it in 5 quarters. The position peaked at $3.16M in Q2 2024. 1,513 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

Pier 88 Investment Partners reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
Pier 88 Investment Partners sold 14,200 Boston Scientific shares in Q4 2024, an estimated $1.19M.
Pier 88 Investment Partners first reported a position in Boston Scientific in Q2 2023 and held it in 5 quarters.
Pier 88 Investment Partners's Boston Scientific position peaked at $3.16M in Q2 2024.
1,513 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Pier 88 Investment Partners's 13F filing for Q4 2024, filed 12 Feb 2025.